<?xml version="1.0"?>
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:title>Prevalence, risk factors, and impact of isolated antibody to hepatitis b core antigen and occult hepatitis b virus infection in hiv-1-infected pregnant women</dc:title>
  <dc:creator>Khamduang, W.</dc:creator>
  <dc:creator>/Ngo-Giang-Huong, Nicole</dc:creator>
  <dc:creator>Gaudy-Graffin, C.</dc:creator>
  <dc:creator>/Jourdain, Gonzague</dc:creator>
  <dc:creator>Suwankornsakul, W.</dc:creator>
  <dc:creator>Jarupanich, T.</dc:creator>
  <dc:creator>Chalermpolprapa, V.</dc:creator>
  <dc:creator>Nanta, S.</dc:creator>
  <dc:creator>Puarattana-aroonkorn, N.</dc:creator>
  <dc:creator>Tonmat, S.</dc:creator>
  <dc:creator>/Lallemant, Marc</dc:creator>
  <dc:creator>Goudeau, A.</dc:creator>
  <dc:creator>Sirirungsi, W.</dc:creator>
  <dc:subject>HIV-1-infected pregnant women</dc:subject>
  <dc:subject>isolated anti-HBc</dc:subject>
  <dc:subject>occult HBV infection</dc:subject>
  <dc:subject>perinatal transmission</dc:subject>
  <dc:description>Background. Prevalence and risk factors for isolated antibody to hepatitis B core antigen (anti-HBc) and occult hepatitis B virus (HBV) infection are not well known in human immunodeficiency virus type 1 (HIV-1)-infected pregnant women. It is unclear if women with occult infections are at risk of transmitting HBV to their infants. Methods. HIV-1-infected and HBV surface antigen (HBsAg)-negative pregnant women were tested for anti-body to HBsAg (anti-HBs) and anti-HBc using enzyme immunoassay. Women with isolated anti-HBc were assessed for occult HBV infection, defined as HBV DNA levels &gt;15 IU/mL, using the Abbott RealTime HBV DNA assay. Infants born to women with isolated anti-HBc and detectable HBV DNA were tested at 4 months of age for HBV DNA. Logistic regression analysis was used to identify factors associated with isolated anti-HBc and occult HBV infection. Results. Among 1812 HIV-infected pregnant women, 1682 were HBsAg negative. Fourteen percent (95% confidence interval [CI], 12%-15%) of HBsAg-negative women had an isolated anti-HBc that was independently associated with low CD4 count, age &gt;35 years, birth in northern Thailand, and positive anti-hepatitis C virus serology. Occult HBV infection was identified in 24% (95% CI, 18%-30%) of women with isolated anti-HBc, representing 2.6% (95% CI, 1.9%-3.5%) of HIV-1-infected pregnant women, and was inversely associated with HIV RNA levels. None of the women with isolated anti-HBc and occult HBV infection transmitted HBV to their infants. Conclusions. HIV-1-infected pregnant women with isolated anti-HBc and occult HBV infection have very low HBV DNA levels and are thus at very low risk to transmit HBV to their infants.</dc:description>
  <dc:date>2013</dc:date>
  <dc:type>text</dc:type>
  <dc:identifier>https://www.documentation.ird.fr/hor/fdi:010060135</dc:identifier>
  <dc:identifier>fdi:010060135</dc:identifier>
  <dc:identifier>Khamduang W., Ngo-Giang-Huong Nicole, Gaudy-Graffin C., Jourdain Gonzague, Suwankornsakul W., Jarupanich T., Chalermpolprapa V., Nanta S., Puarattana-aroonkorn N., Tonmat S., Lallemant Marc, Goudeau A., Sirirungsi W.. Prevalence, risk factors, and impact of isolated antibody to hepatitis b core antigen and occult hepatitis b virus infection in hiv-1-infected pregnant women. 2013, 56 (12),  1704-1712</dc:identifier>
  <dc:language>EN</dc:language>
  <dc:coverage>THAILANDE</dc:coverage>
</oai_dc:dc>
